E Seböková

4.2k total citations
102 papers, 2.2k citations indexed

About

E Seböková is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, E Seböková has authored 102 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Endocrinology, Diabetes and Metabolism, 35 papers in Molecular Biology and 25 papers in Physiology. Recurrent topics in E Seböková's work include Diet, Metabolism, and Disease (21 papers), Adipose Tissue and Metabolism (20 papers) and Peroxisome Proliferator-Activated Receptors (18 papers). E Seböková is often cited by papers focused on Diet, Metabolism, and Disease (21 papers), Adipose Tissue and Metabolism (20 papers) and Peroxisome Proliferator-Activated Receptors (18 papers). E Seböková collaborates with scholars based in Slovakia, Switzerland and Canada. E Seböková's co-authors include I Klimeś, M. Thomas Clandinin, Manohar L. Garg, A. B. R. Thomson, Daniela Gašperíková, P Langer, Žofia Rádiková, T. Trnovec, Jacques Mizrahi and M Tajtáková and has published in prestigious journals such as Circulation, Biochemical Journal and Chemosphere.

In The Last Decade

E Seböková

100 papers receiving 2.2k citations

Peers

Countries citing papers authored by E Seböková

Since Specialization

Citations

This map shows the geographic impact of E Seböková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Seböková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Seböková more than expected).

Fields of papers citing papers by E Seböková

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Seböková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Seböková. The network helps show where E Seböková may publish in the future.

Co-authorship network of co-authors of E Seböková

This figure shows the co-authorship network connecting the top 25 collaborators of E Seböková. A scholar is included among the top collaborators of E Seböková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Seböková. E Seböková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats 2011 ·Journal of Endocrinology ·Rana Samadfam, (unknown), Agnès Bénardeau, Frieder Bauss, E Seböková, Matthew Wright, Susan Y. Smith	12
2	Abstract 10854: Aleglitazar, a Balanced Dual PPAR alpha/ gamma Agonist, Decreases Lipolysis and Cytokine Production in a Cellular Model of Inflamed Human Adipose Tissue. 2010 ·Circulation ·(unknown), Matthew B. Wright, E Seböková, Martin Wabitsch, Pamela Fischer‐Posovszky, Michaela Keuper, Kurt E. Amrein	4
3	Medium‐chain fatty acids ameliorate insulin resistance caused by high‐fat diets in rats 2009 ·Diabetes/Metabolism Research and Reviews ·Silvia Wein, Siegfried Wolffram, Jürgen Schrezenmeir, Daniela Gašperíková, I Klimeś, E Seböková	64
4	Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules 2008 ·Atherosclerosis ·Chris Tikellis, Karin Jandeleit‐Dahm, Karen Sheehy, Andrew Murphy, Jaye Chin‐Dusting, (unknown), E Seböková, Mark E. Cooper, Jacques Mizrahi, Kevin Woollard	28
5	Increased thyroid volume, prevalence of thyroid antibodies and impaired fasting glucose in young adults from organochlorine cocktail polluted area: Outcome of transgenerational transmission? 2008 ·Chemosphere ·P Langer, Anton Koc̆an, M Tajtáková, Juraj Koška, Žofia Rádiková, L Kšinantová, Richard Imrich, Miloslava Hučková, Beata Drobná, Daniela Gašperíková, E Seböková, I Klimeś	35
6	Concerted Action of Leptin in Regulation of Fatty Acid Oxidation in Skeletal Muscle and Liver 2007 ·Experimental and Clinical Endocrinology & Diabetes ·Sharon Wein, Jozef Ukropec, Daniela Gašperíková, I Klimeś, E Seböková	22
7	PPARs and Diabetes-Associated Atherosclerosis 2007 ·Current Pharmaceutical Design ·Anna C. Calkin, Karin Jandeleit‐Dahm, Terri J. Allen, Jacques Mizrahi, M. E. Cooper, (unknown), E Seböková	6
8	Insulin Sensitivity Indices: a Proposal of Cut-Off Points for Simple Identification of Insulin-Resistant Subjects 2006 ·Experimental and Clinical Endocrinology & Diabetes ·Žofia Rádiková, J Koška, Miroslava Hučková, L Kšinantová, Richard Imrich, M Vigaš, T. Trnovec, P. Langer, E Seböková, I Klimeś	131
9	Mapping of genetic loci predisposing to hypertriglyceridaemia in the hereditary hypertriglyceridaemic rat: analysis of genetic association with related traits of the insulin resistance syndrome 2003 ·Diabetologia ·I Klimeś, (unknown), Péter Kovács, Daniela Gašperíková, Daniela Ježová, Richard Květňanský, John R. Thompson, E Seböková, Nilesh J. Samani	18
10	High Prevalence of Anti-Glutamic Acid Decarboxylase (Anti-GAD) Antibodies in Employees at a Polychlorinated Biphenyl Production Factory 2002 ·Archives of Environmental Health An International Journal ·P Langer, M Tajtáková, (unknown), Anton Koc̆an, Ján Petrı́k, Jana Chovancová, Beata Drobná, Stanislav Jursa, Marián Pavúk, T. Trnovec, E Seböková, I Klimeś	41
11	[Epidemiological profile of thyroid volume and disorders in Slovakia]. 2000 ·PubMed ·M Tajtáková, P Langer, (unknown), (unknown), Zsuzsanna Putz, (unknown), Joel Michalek, A Kréze, I Klimeś, E Seböková	2
12	Lipids and syndromes of insulin resistance : from molecular biology to clinical medicine 1997 ·New York Academy of Sciences eBooks ·I Klimeś, S. M. Haffner, E Seböková, B. V. Howard, L. H. Storlien	2
13	Diet‐induced Insulin Resistance Is Associated with Decreased Activity of Type I Iodothyronine 5′‐Deiodinase in Rat Liver^a 1997 ·Annals of the New York Academy of Sciences ·(unknown), (unknown), E Seböková, I Klimeś, P Langer, Július Brtko	2
14	The Effect of Hyperlipidemia on Serum Fatty Acid Composition in Type 2 Diabetics^a 1997 ·Annals of the New York Academy of Sciences ·Pavol Bohov, (unknown), E Seböková, I Klimeś	16
15	Glucose Transport and Insulin Signaling in Rat Muscle and Adipose Tissue Effect of Lipid Availability^a 1997 ·Annals of the New York Academy of Sciences ·Daniela Gašperíková, I Klimeś, Thomas Kolter, Pavol Bohov, (unknown), Jürgen Eckel, M. Thomas Clandinin, E Seböková	7
16	Hypertension and the Insulin Resistance Syndrome of Rats 1997 ·Annals of the New York Academy of Sciences ·I Klimeś, E Seböková	9
17	[Cellular and molecular mechanisms of insulin resistance]. 1995 ·PubMed ·E Seböková, I Klimeś, P Stolba	1
18	Raised Dietary Intake of N‐3 Polyunsaturated Fatty Acids in High Sucrose‐Induced Insulin Resistance 1993 ·Annals of the New York Academy of Sciences ·I Klimeś, E Seböková, A Vrána, (unknown)	32
19	Effect of Dietary Fish Oil on 2‐Deoxy‐D‐³H Glucose Uptake in Isolated Adipocytes of Rats Fed Various Diets ^a 1993 ·Annals of the New York Academy of Sciences ·L Macho, M Ficková, E Seböková, (unknown), I Klimeś	5
20	Liver Plasma Membrane Lipid Composition and Insulin Receptor Tyrosine Kinase Activity in HTG Rat 1992 ·Hormone and Metabolic Research ·M Ficková, E Seböková, P. Hubert, Cathy Staedel, (unknown), Jiřı́ Klimeš, Gérard Crémel, L Macho	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact